Altre lingue Cannara Biotech Inc.

Azioni

LOVE

CA13765U2002

Mercato chiuso - Toronto S.E. Altri mercati azionari 20:05:41 09/05/2024			Variaz. 5gg	Var. 1 gen.
0,78 ^CAD	+5,41%		-2,50%	-6,02%

29/04	Cannara Biotech diventa negativa e riporta una perdita netta più ampia nel secondo trimestre rispetto all'anno precedente, nonostante un aumento delle entrate del 51%.	MT
29/04	Cannara Biotech Inc. riporta i risultati degli utili per il secondo trimestre e i sei mesi conclusi il 29 febbraio 2024	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Cannara Biotech Turns Negative As Reports Wider Q2 Net Loss Vs a Year Ago, Despite Revenue up 51%	29/04
Cannara Biotech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended February 29, 2024	29/04
Cannara Biotech Reports Q2 2024 Financial Results	29/04
Cannara Biotech CFO Nicholas Sosiak: Unveiling Success Strategies and Future Plans	08/02
Cannara Biotech Inc. Reports Earnings Results for the First Quarter Ended November 30, 2023	29/01
Cannara Biotech to Host Investor Webcast on Thursday December 14th, 2023	11/12
Cannara Biotech Inc. Reports Earnings Results for the Full Year Ended August 31, 2023	07/12
Cannara Biotech's Fiscal Q4 Profit, Revenue Grows; Up 9.4%	07/12
Cannara Biotech Inc. Reports Earnings Results for the Fourth Quarter Ended August 31, 2023	07/12
Tranche Update on Cannara Biotech Inc.'s Equity Buyback Plan announced on November 30, 2022.	27/07/23
Cannara Biotech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended May 31, 2023	27/07/23
Cannara Biotech Inc. Reports Record Q3 2023 Financial Results with Net Revenues of $15.9 Million and Net Income of $2.9 million	27/07/23
Cannara Biotech Inc Announces Participation in the LD Micro Invitational XIII	23/05/23
Tranche Update on Cannara Biotech Inc.'s Equity Buyback Plan announced on November 30, 2022.	24/04/23
Cannara Biotech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended February 28, 2023	24/04/23
Cannara Biotech Down Near 8% As Enters into an Automatic Share Purchase Plan	28/02/23
Cannara Biotech Inc. Enters into an Automatic Share Purchase Plan	28/02/23
Cannara biotech inc. Announces results of annual shareholder meeting and conversion into equity of a $5m convertible debenture at $0.18 cent per common share	13/02/23
Cannara Biotech Converts CA$5 Million Debenture, Plus Interest, into Nearly 30 Million Shares for Olymbec Investments	10/02/23
Tranche Update on Cannara Biotech Inc.'s Equity Buyback Plan announced on November 30, 2022.	23/01/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Cannara Biotech Inc.

Azioni

LOVE

CA13765U2002

Altre lingue

Filtri